Abstract
People commonly inquire about vitamin and mineral supplementation and diet as a means to prevent or manage dermatological diseases and, in particular, hair loss. Answering these queries is frequently challenging, given the enormous and conflicting evidence that exists on this subject. There are several reasons to suspect a role for micronutrients in non-scarring alopecia. Micronutrients are major elements in the normal hair follicle cycle, playing a role in cellular turnover. The role of nutrition and diet in treating hair loss represents a dynamic and growing area of inquiry. This chapter summarizes the role of vitamins and minerals in non-scarring alopecia. Micronutrients such as vitamins and minerals play an important, but not entirely clear role in normal hair follicle development and immune cell function. Deficiency of such micronutrients may represent a modifiable risk factor associated with development, prevention, and treatment of alopecia.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Hair loss
- Alopecia
- Alopecia areata
- Androgenetic alopecia
- Biotin
- Ferritin
- Folic acid
- Iron
- Selenium
- Telogen effluvium
- Vitamin A
- Vitamin B
- Vitamin C
- Vitamin D
- Vitamin E
- Zinc
Introduction
People commonly inquire about vitamin and mineral supplementation and diet as a means to prevent or manage hair loss. Answering these queries is frequently challenging, given the enormous and conflicting evidence that exists on this subject.
Vitamin A
In most cases, a balanced diet will supply a healthy amount of vitamin A [1]. The recommended dietary allowance of vitamin A for adults 19 years or older is 1300 μg/day (4300 units) for US populations. While there is no upper intake level for provitamin A carotenoids, preformed vitamin A can be toxic. For adults 19 years or older, the tolerable upper intake level is 10,000 IU [2]. It is important to consider what form of vitamin A is contained in supplements (provitamin A carotenoids or preformed vitamin A) and in what proportion.
In general, consuming too much or over-supplementing vitamin A can cause hair loss [3,4,5,6].
The same advice generally applies to vitamin A derivatives because isotretinoin is a well-known cause of hair loss, causing a decrease in hair count, density, and percentage of anagen hairs [7].
When treating patients with a personal or family history of androgenetic alopecia (AGA) with isotretinoin, always prescribe a treatment to prevent hair loss.
Vitamin B
Only riboflavin, biotin, folate, and vitamin B 12 deficiencies have been associated with hair loss, but data are not very strong. Vitamin B2 (riboflavin) is a component of two important coenzymes: flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) [8]. FMN and FAD represent 90% of dietary riboflavin and play roles in cellular development and function, metabolism of fats, and energy production [9]. The body stores only small amounts of riboflavin in the liver, heart, and kidneys. Riboflavin deficiency—while extremely rare in the United States—can cause hair loss [10].
Biotin (vitamin B7 or vitamin H) is a common ingredient of hair loss supplements. Adequate intake of biotin for adults is 30 μg/day in US populations. The average dietary intake of biotin in Western countries is adequate, and biotin deficiency in healthy individuals eating a normal diet has never been reported [11, 12]. However, a deficiency can occur in patients with inflammatory bowel diseases, malabsorption, alcoholism, after treatment with broad-spectrum antibiotics, valproic acid or isotretinoin, in parenteral nutrition, after partial gastrectomy, in elderly individuals, pregnant women, and athletes. Many supplements for hair, skin, and nails far exceed the recommended daily intake of biotin. While there is no evidence for biotin toxicity, high biotin intake can cause falsely high or falsely low lab test results [13].
Biotin can in fact interfere with tests that use biotin-streptavidin technology. Streptavidin which is a biotin-based immunoassay is vulnerable to interference when it is used to analyze a sample that contains biotin. Exogenous biotin in the sample competes with biotinylated reagents for the binding sites on streptavidin reagents creating false-positive or false-negative results [14]. Biotin interference with biotin-streptavidin immunoassays have been described in patient samples for thyroid-stimulating hormone, free tri-iodothyronine (FT3), free thyroxine (FT4), parathyroid hormone, estradiol, testosterone, progesterone, dehydroepiandrosterone sulfate, vitamin B12 , prostate-specific antigen, luteinizing hormone, and follicle-stimulating hormone. Other non-hormonal tests include cardiac and tumor markers, infectious disease serologies, biomarkers of anemia and autoimmune diseases, and concentrations of immunosuppressive drugs [14,15,16,17].
Biotin interference caused a falsely low result in a troponin test that led to a missed diagnosis of a heart attack and a patient’s death [13]. Some hCG devices are subject to biotin interference, and clinicians should suggest quantitative serum hCG measurement in patients taking biotin. The latter is not subject to biotin interference [18].
While signs of biotin deficiency include hair loss, skin rashes, and brittle nails, efficacy of biotin in supplements for hair, skin, and nails has not been assessed in large-scale studies [11, 19]. However case reports have been used to justify the use of biotin supplements for hair growth. These case reports were in children and found that 3–5 mg daily could improve hair health after 3–4 months in children with uncombable hair syndrome [20,21,22,23].
The recommended dietary allowance of food folate is 400 μg daily for adults, which is supported by required fortification of some foods in the United States [8]. The tolerable upper intake level of folate is 1000 μg [24]. While most people in the United States obtain adequate folate, certain groups are at risk for deficiency (usually in association with poor diet, alcoholism, or a malabsorptive disorder). Folate deficiency can cause hair, skin, and nail changes [8].
The recommended dietary allowance of vitamin B12 is 2.4 μg for adult US populations. There is no established upper limit for vitamin B12 intake, as it has low potential for toxicity [8]. The role of folate and vitamin B12 in nucleic acid production suggest they might play a role in the highly proliferative hair follicle [25]. There are not many studies addressing the relationship between B vitamins and hair loss. The effects of low folate and vitamin B12 levels in inducing TE are not supported by high-quality studies [26]. However, we recommend testing levels of folate and vitamin B12 and supplement when low.
Vitamin C
Vitamin C plays an essential role in the intestinal absorption of iron, because of its chelating and reducing effect, assisting iron mobilization and intestinal absorption [27]. Therefore, vitamin C intake is important in patients with hair loss associated with iron deficiency. Although vitamin C deficiency is typically associated with body hair abnormalities [28], there are no data correlating vitamin C levels and hair loss.
Vitamin D
Low vitamin D levels have been reported in several autoimmune diseases [29,30,31,32,33,34]. The role of vitamin D in the hair follicle is evidenced by hair loss in patients with vitamin D-dependent rickets type II. These patients have mutations in the VDR gene producing vitamin D resistance, sparse body hair, and alopecia that frequently involves the whole scalp and body [35,36,37].
Alopecia Areata
Literature data suggests that vitamin D, due to its immunomodulatory effect, may be involved in alopecia areata (AA) [38, 39]. The mean serum 25-hydroxyvitamin D levels in patients with AA were significantly lower than that in the non-AA subjects [40,41,42]. The level of vitamin D showed a significant inverse correlation with disease severity [41, 42]. Therefore, vitamin D level has to be measured and patient should receive supplementation when vitamin D levels are low.
Female Pattern Hair Loss and Telogen Effluvium
Data on vitamin D in female pattern hair loss (FPHL) and telogen effluvium (TE) are contradicting with studies indicating that women with FPHL or TE have lower levels of vitamin D than controls, and studies showing no correlation or even opposite results [43,44,45,46,47]. However, we recommend checking vitamin D levels and supplementing vitamin D in patients who have low levels (below 30 nmol/L).
Vitamin E
Vitamin E is involved in the oxidant/antioxidant balance and helps to protect against free-radical damage [48].
Iron
The most common nutritional deficiency in the world is iron deficiency , which contributes to TE [49, 50]. Serum ferritin (iron-binding protein) is considered a good indicator of body iron stores and is relied upon in hair loss studies. Serum ferritin concentration is used to measure a patient’s total iron storage [51]. However, serum ferritin levels may be raised in patients with inflammatory, infectious and neoplastic conditions, and liver disorders.
Iron deficiency is common in women with hair loss [52]. Nevertheless, the association of hair loss and low serum ferritin level has been debated over the years [53]. Using serum ferritin levels as a marker for iron -storage deficiency, the definition of iron deficiency (but not specifically iron deficiency anemia) ranges from levels of less than or equal to 15 μg/L to levels of less than 70 μg/L [54,55,56,57,58,59]. A cut-off of 30 μg/L has a sensitivity and specificity in detecting iron deficiency of 92% and 98%, respectively. We usually prescribe ferritin supplementation in women with iron levels below 30 ng/dL. Of note, L-lysine supplementation (1.5–2 g/day) is recommended for vegetarian/vegan individuals with iron deficiency [52].
Selenium, Copper, Magnesium
Selenium is an essential trace element required for synthesis of more than 35 proteins. Glutathione peroxidase (antioxidant enzyme) depends on selenium as a co-factor. Selenium deficiency occurs in low birth weight infants and in patients requiring total parenteral nutrition (TPN). It can also occur in a location where the soil lacks selenium [60].
Loss of pigmentation of the hair has been described in patients receiving TPN without selenium supplementation. Hair started to re-pigment after 6–12 months of therapy with intravenous selenium [61]. Similar findings including alopecia with pseudoalbinism were found in infants receiving nutritional support. After starting daily selenium therapy (5 μg/kg/day), selenium serum levels returned to the normal range of 5–15 μg/dL, and alopecia and pseudoalbinism improved [62].
Selenium supplementation is a supportive element in chemotherapy as it may significantly decrease hair loss and other gastrointestinal symptoms [63]. The recommended dietary allowance is 55 μg daily for individuals 14 years or older in US populations. The availability of selenium in a variety of foods, e.g., meat, vegetables, and nuts, is sufficient for the daily requirement [64]. Selenium ingestion in an amount exceeding 400 μg daily may cause toxicity. Symptoms of acute or chronic selenium toxicity include nausea, vomiting, nail brittleness and discolorations, hair loss, fatigability, irritability, and foul breath odor [64, 65].
Copper acts with zinc in the antioxidant enzyme copper/zinc superoxide dismutase [66]. Magnesium acts as a cofactor for over 300 enzymes and plays a critical role in nucleotide synthesis, a frequent process in the rapidly dividing hair follicle [67]. Evidence are conflicting and insufficient to suggest to dose levels of copper and magnesium in AA [34].
Zinc
Zinc is an essential trace element, which means that the body cannot generate it by its own, and it must be supplied through the diet. Dietary sources include fish and meat. Zinc deficiency can occur in patients consuming large amounts of cereal grain (which contain a phytate considered a chelating agent of zinc), with poor meat consumption, total parenteral nutrition , and milk formula for infants. Other causes of zinc deficiency include anorexia nervosa (secondary to inadequate intake, increased zinc excretion, and malabsorption due to laxative abuse), inflammatory bowel disease, jejunal bypass surgery, and cystic fibrosis. Alcoholism , malignancy, burns, infection, and pregnancy may all cause increased metabolism and excretion of zinc.
Alopecia is a well-known sign of established zinc deficiency with hair regrowth occurring with zinc supplementation [68, 69]. Data correlating zinc levels with TE and AGA are not homogeneous and role of zinc supplementation is debated [70]. Zinc supplementation has been utilized in AA with conflicting results [34].
Premature Graying of Hair
The process of gray hair seems to be associated with the progressive loss of pigment-producing cells. Premature graying of hair is considered when it occurs before the age of 20 in whites, 25 in Asians, and 30 in Africans [71]. Premature graying or canities is associated with several autoimmune disorders such as vitiligo, thyroid disease, pernicious anemia, and Werner’s syndrome. Moreover, data suggest a role for external factors such as climate, ultraviolet light, drugs, smoking, minerals, and nutritional deficiencies in the development of premature graying [72].
Patients should be checked for levels of calcium, ferritin, vitamin D, biotin, vitamin B12, folic acid, copper, and selenium and supplemented when deficient [70].
Plants with Medical Properties
Several botanically derived compounds have showed the ability to inhibit hormonal pathways associated with AGA. Notably, these botanical products have not been linked with adverse reactions or teratogenicity associated with the therapeutic drugs [73]. Recently, a few studies have reported the efficacy of botanical substances in the treatment of AGA. Lists of medical plants used to regrow hairs are summarized in Tables 7.1, 7.2, and 7.3. Additional information on nutritional supplements investigated for treatment of TE or hair thinning are summarized in Chap. 10, Table 10.7.
Summary
Telogen Effluvium/Androgenetic Alopecia
Although the relationship between vitamin D levels and AGA or TE are still debated, most authors agree about supplementing vitamin D in patients with hair loss and vitamin D deficiency. Vitamin C intake is crucial in patients with hair loss associated with iron deficiency. There are no data to support the role of vitamin E in AGA or TE.
Most authors agree in supplementing iron in patients with iron deficiency and/or low ferritin levels. However, there is no consensus on “normal ferritin” levels; we recommend to supplement patient when ferritin is below 30 μg/L. Data correlating TE and AGA with zinc level are not homogenous, and screening for zinc is not recommended. The same applies for selenium and riboflavin.
Biotin deficiency causes hair loss, but there are no evidence-based data that supplementing biotin promotes hair growth. Moreover, exogenous biotin interferes with some laboratory tests creating false-negative or false-positive results. There are a few studies addressing the relationship between hair loss and folic acid or vitamin B12. We recommend screening patients for these vitamins. Hypervitaminosis A causes hair loss and dosing vitamin A can be important in patients taking multivitamins and food rich in vitamin A in their diet.
Alopecia Areata
Several studies show an association between AA and low vitamin D levels. Patients should be checked and given supplementation if vitamin D levels are low. Also, we recommend iron supplementation if ferritin levels are below 30 μg/L.
Most studies on zinc revealed lower serum levels in AA patients compared to controls. However, double-blind trials investigating zinc supplementation in AA is lacking.
A few studies suggest that the levels of folate or vitamin B12 might modify progression of AA, but data are still too small to recommend screening or supplementation of B vitamins. Biotin supplementation has been successful in the treatment of brittle nails [98]. There are no studies of biotin as monotherapy for AA.
Premature Canities
There are a few micronutrients implicated in the pigment loss of the hair; they include ferritin, vitamin D, folate, vitamin B12, biotin, calcium, copper, and selenium deficiency. We recommend screening for these vitamins and minerals in patients presenting with premature graying of hair and supplementation of deficient micronutrients.
Medical Plants Used for Hair Loss Treatment
There are some botanicals that inhibit 5α-reductase enzymes, have anti-inflammatory effects, or may stimulate hair growth . Among these botanicals, studies showed that Serenoa repens, saw palmetto, Malus domestica, and marine derivative products were the most used plants for hair loss.
References
Vitamins and Minerals: B Vitamins and Folic Acid NHS Choices: National Health Service; 2017. Available from: https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-b/.
Board IoMFaN. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper. iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academies Press; 2001.
Yamamoto K, Sadahito K, Yoshikawa M, Nobuyuki O, Mikami O, Yamada M, et al. Hyena disease (premature physeal closure) in calves due to overdose of vitamins A, D3, E. Vet Hum Toxicol. 2003;45(2):85–7.
McLaren DSLN, Duthie G, Bolton-Smith C. Fat soluble vitamins. In: Garrow JS, James WPT, editors. Human nutrition, dietetics. 9th ed. Edinburgh: Churchill Livingstone; 1993.
Shmunes E. Hypervitaminosis A in a patient with alopecia receiving renal dialysis. Arch Dermatol. 1979;115(7):882–3.
Cheruvattath R, Orrego M, Gautam M, Byrne T, Alam S, Voltchenok M, et al. Vitamin A toxicity: when one a day doesn’t keep the doctor away. Liver Transpl. 2006;12(12):1888–91.
Kmiec ML, Pajor A, Broniarczyk-Dyla G. Evaluation of biophysical skin parameters and assessment of hair growth in patients with acne treated with isotretinoin. Postepy Dermatol Alergol. 2013;30(6):343–9.
Board IoMFaN. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academies Press; 1998.
Said HM, Ross AC. Riboflavin. In: Modern nutrition in health and disease. 11th ed. Baltimore: Lippincott Williams & Wilkins; 2014. p. 325–30.
Rivlin RS. Riboflavin. In: Encyclopedia of dietary supplements. London and New York: Informa Healthcare; 2010. p. 691–9.
Mock DM. Biotin. In: Encyclopedia of dietary supplements. 2nd ed. London and New York: Informa Healthcare; 2010. p. 43–51.
Tzellos TG, Tahmatzidis DK, Lallas A, Apostolidou K, Goulis DG. Pernicious anemia in a patient with type 1 diabetes mellitus and alopecia areata universalis. J Diabetes Complicat. 2009;23(6):434–7.
FDA. The FDA warns that biotin may interfere with lab tests: FDA safety communication U.S. Food & Drug Administration: U.S. Department of Health and Human Services; 2017 (updated 28 Nov 2017). Available from: https://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm586505.htm.
Samarasinghe S, Meah F, Singh V, Basit A, Emanuele N, Emanuele MA, et al. Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks. Endocr Pract. 2017;23(8):989–98.
Wijeratne NG, Doery JC, Lu ZX. Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study. Pathology. 2012;44(7):674–5.
Trambas CM, Sikaris KA, Lu ZX. More on biotin treatment mimicking Graves’ disease. N Engl J Med. 2016;375(17):1698.
Batista MC, Ferreira CES, Faulhaber ACL, Hidal JT, Lottenberg SA, Mangueira CLP. Biotin interference in immunoassays mimicking subclinical Graves’ disease and hyperestrogenism: a case series. Clin Chem Lab Med. 2017;55(6):e99–e103.
Williams GR, Cervinski MA, Nerenz RD. Assessment of biotin interference with qualitative point-of-care hCG test devices. Clin Biochem. 2018;53:168–70.
Zempleni J, Wijeratne S, Kuroishi T. Biotin. In: Present knowledge in nutrition. 10th ed. Washington, DC: Wiley-Blackwell; 2012. p. 359–74.
Boccaletti V, Zendri E, Giordano G, Gnetti L, De Panfilis G. Familial uncombable hair syndrome: ultrastructural hair study and response to biotin. Pediatr Dermatol. 2007;24(3):E14–6.
Shelley WB, Shelley ED. Uncombable hair syndrome: observations on response to biotin and occurrence in siblings with ectodermal dysplasia. J Am Acad Dermatol. 1985;13(1):97–102.
Trueb RM. Serum biotin levels in women complaining of hair loss. Int J Trichology. 2016;8(2):73–7.
Durusoy C, Ozenli Y, Adiguzel A, Budakoglu IY, Tugal O, Arikan S, et al. The role of psychological factors and serum zinc, folate and vitamin B12 levels in the aetiology of trichodynia: a case-control study. Clin Exp Dermatol. 2009;34(7):789–92.
Bailey RL, Dodd KW, Gahche JJ, Dwyer JT, McDowell MA, Yetley EA, et al. Total folate and folic acid intake from foods and dietary supplements in the United States: 2003-2006. Am J Clin Nutr. 2010;91(1):231–7.
Harvard T.H. Chan School of Public Health. Three of the B vitamins: folate, vitamin B6, and vitamin B12. Boston: Harvard T.H. Chan School of Public Health; 2018.. (updated 8 Aug 2018).
Cheung EJ, Sink JR, English JC III. Vitamin and mineral deficiencies in patients with telogen effluvium: a retrospective cross-sectional study. J Drugs Dermatol. 2016;15(10):1235–7.
Valdes F. [Vitamin C]. Actas Dermosifiliogr. 2006;97(9):557–68.
Fleming JD, Martin B, Card DJ, Mellerio JE. Pain, purpura and curly hairs. Clin Exp Dermatol. 2013;38(8):940–2.
D’Aurizio F, Villalta D, Metus P, Doretto P, Tozzoli R. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev. 2015;14(5):363–9.
Zhang X, Wang W, Li Y, Wang H, Liu R, Zhu L. Serum 25-hydroxyvitamin D status in chinese children with vitiligo: a case-control study. Clin Pediatr (Phila). 2018;57(7):802–5.
Djeraba Z, Benlabidi F, Djaballah-Ider FZ, Medjeber O, Arroul-Lammali A, Belguendouz H, et al. Vitamin D status in Algerian Behcet’s disease patients: an immunomodulatory effect on NO pathway. Immunopharmacol Immunotoxicol. 2017;39(4):243–50.
Wang LM, Zheng ZH, Li TF, Han LS, He YJ, Zhang YL, et al. 25-hydroxyvitamin D is associated with metabolic syndrome among premenopausal women with systemic lupus erythematosus in China. Lupus. 2017;26(4):403–9.
Vasile M, Corinaldesi C, Antinozzi C, Crescioli C. Vitamin D in autoimmune rheumatic diseases: a view inside gender differences. Pharmacol Res. 2017;117:228–41.
Thompson JM, Mirza MA, Park MK, Qureshi AA, Cho E. The role of micronutrients in alopecia areata: a review. Am J Clin Dermatol. 2017;18(5):663–79.
Takeda E, Kuroda Y, Saijo T, Naito E, Kobashi H, Yokota I, et al. 1 Alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia. Pediatrics. 1987;80(1):97–101.
Malloy PJ, Pike JW, Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev. 1999;20(2):156–88.
Vupperla D, Lunge SB, Elaprolu P. Vitamin D-dependent rickets type II with alopecia: a rare case report. Indian J Dermatol. 2018;63(2):176–9.
Aksu Cerman A, Sarikaya Solak S, Kivanc Altunay I. Vitamin D deficiency in alopecia areata. Br J Dermatol. 2014;170(6):1299–304.
Mahamid M, Abu-Elhija O, Samamra M, Mahamid A, Nseir W. Association between vitamin D levels and alopecia areata. Isr Med Assoc J. 2014;16(6):367–70.
Lee S, Kim BJ, Lee CH, Lee WS. Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2018;32(7):1214–21.
Gade VKV, Mony A, Munisamy M, Chandrashekar L, Rajappa M. An investigation of vitamin D status in alopecia areata. Clin Exp Med. 2018;18(4):577–84.
Daroach M, Narang T, Saikia UN, Sachdeva N, Sendhil Kumaran M. Correlation of vitamin D and vitamin D receptor expression in patients with alopecia areata: a clinical paradigm. Int J Dermatol. 2018;57(2):217–22.
Rasheed H, Mahgoub D, Hegazy R, El-Komy M, Abdel Hay R, Hamid MA, et al. Serum ferritin and vitamin d in female hair loss: do they play a role? Skin Pharmacol Physiol. 2013;26(2):101–7.
Banihashemi M, Nahidi Y, Meibodi NT, Jarahi L, Dolatkhah M. Serum vitamin D3 level in patients with female pattern hair loss. Int J Trichology. 2016;8(3):116–20.
Moneib H, Fathy G, Ouda A. Possible association of female-pattern hair loss with alteration in serum 25-hydroxyvitamin D levels. Egypt J Dermatol Venerol. 2014;34:15–20.
Nayak K, Garg A, Mithra P, Manjrekar P. Serum vitamin D3 levels and diffuse hair fall among the student population in South India: a case-control study. Int J Trichology. 2016;8(4):160–4.
Karadag AS, Ertugrul DT, Tutal E, Akin KO. The role of anemia and Vitamin D levels in acute and chronic telogen effluvium. Turk J Med Sci. 2011;41:827–33.
Naziroglu M, Kokcam I. Antioxidants and lipid peroxidation status in the blood of patients with alopecia. Cell Biochem Funct. 2000;18(3):169–73.
Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006;54(5):824–44.
Shrivastava SB. Diffuse hair loss in an adult female: approach to diagnosis and management. Indian J Dermatol Venereol Leprol. 2009;75(1):20–7; quiz 7–8.
Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol. 1973;26(10):770–2.
Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol. 2002;27(5):396–404.
Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol. 2002;147(5):982–4.
Coenen JL, van Dieijen-Visser MP, van Pelt J, van Deursen CT, Fickers MM, van Wersch JW, et al. Measurements of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease. Clin Chem. 1991;37(4):560–3.
Rushton DH, Ramsay ID. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women. Clin Endocrinol. 1992;36(4):421–7.
Milman N, Kirchhoff M. Iron stores in 1359, 30- to 60-year-old Danish women: evaluation by serum ferritin and hemoglobin. Ann Hematol. 1992;64(1):22–7.
Hallberg L, Bengtsson C, Lapidus L, Lindstedt G, Lundberg PA, Hulten L. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol. 1993;85(4):787–98.
Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89(3):1052–7.
Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998;44(1):45–51.
Goldberg LJ, Lenzy Y. Nutrition and hair. Clin Dermatol. 2010;28(4):412–9.
Vinton NE, Dahlstrom KA, Strobel CT, Ament ME. Macrocytosis and pseudoalbinism: manifestations of selenium deficiency. J Pediatr. 1987;111(5):711–7.
Masumoto K, Nagata K, Higashi M, Nakatsuji T, Uesugi T, Takahashi Y, et al. Clinical features of selenium deficiency in infants receiving long-term nutritional support. Nutrition. 2007;23(11–12):782–7.
Petru E, Petru C, Benedicic C. Re: “Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy”. Gynecol Oncol. 2005;96(2):559; author reply 559–60.
Fan AM, Kizer KW. Selenium. Nutritional, toxicologic, and clinical aspects. West J Med. 1990;153(2):160–7.
MacFarquhar JK, Broussard DL, Melstrom P, Hutchinson R, Wolkin A, Martin C, et al. Acute selenium toxicity associated with a dietary supplement. Arch Intern Med. 2010;170(3):256–61.
Abdel Fattah NS, Atef MM, Al-Qaradaghi SM. Evaluation of serum zinc level in patients with newly diagnosed and resistant alopecia areata. Int J Dermatol. 2016;55(1):24–9.
Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. The National Academies Collection: reports funded by National Institutes of Health. Washington, DC: National Academies Press; 1997.
Goskowicz M, Eichenfield LF. Cutaneous findings of nutritional deficiencies in children. Curr Opin Pediatr. 1993;5(4):441–5.
Alhaj E, Alhaj N, Alhaj NE. Diffuse alopecia in a child due to dietary zinc deficiency. Skinmed. 2007;6(4):199–200.
Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A. The role of vitamins and minerals in hair loss: a review. Dermatol Ther (Heidelb). 2019;9(1):51–70.
Trueb RM. Pharmacologic interventions in aging hair. Clin Interv Aging. 2006;1(2):121–9.
Fatemi Naieni F, Ebrahimi B, Vakilian HR, Shahmoradi Z. Serum iron, zinc, and copper concentration in premature graying of hair. Biol Trace Elem Res. 2012;146(1):30–4.
Klepser TB, Klepser ME. Unsafe and potentially safe herbal therapies. Am J Health Syst Pharm. 1999;56(2):125–38; quiz 39–41.
Prager N, Bickett K, French N, Marcovici G. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med. 2002;8(2):143–52.
Rossi A, Mari E, Scarno M, Garelli V, Maxia C, Scali E, et al. Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. Int J Immunopathol Pharmacol. 2012;25(4):1167–73.
Matsuda H, Yamazaki M, Asanuma Y, Kubo M. Promotion of hair growth by ginseng radix on cultured mouse vibrissal hair follicles. Phytother Res. 2003;17(7):797–800.
Murata K, Noguchi K, Kondo M, Onishi M, Watanabe N, Okamura K, et al. Inhibitory activities of Puerariae Flos against testosterone 5alpha-reductase and its hair growth promotion activities. J Nat Med. 2012;66(1):158–65.
Kumar N, Rungseevijitprapa W, Narkkhong NA, Suttajit M, Chaiyasut C. 5alpha-reductase inhibition and hair growth promotion of some Thai plants traditionally used for hair treatment. J Ethnopharmacol. 2012;139(3):765–71.
Esfandiari A, Kelly AP. The effects of tea polyphenolic compounds on hair loss among rodents. J Natl Med Assoc. 2005;97(8):1165–9.
Shimizu K, Kondo R, Sakai K, Shoyama Y, Sato H, Ueno T. Steroid 5alpha-reductase inhibitory activity and hair regrowth effects of an extract from Boehmeria nipononivea. Biosci Biotechnol Biochem. 2000;64(4):875–7.
Park WS, Lee CH, Lee BG, Chang IS. The extract of Thujae occidentalis semen inhibited 5alpha-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse. J Dermatol Sci. 2003;31(2):91–8.
Murata K, Noguchi K, Kondo M, Onishi M, Watanabe N, Okamura K, et al. Promotion of hair growth by Rosmarinus officinalis leaf extract. Phytother Res. 2013;27(2):212–7.
Wikramanayake TC, Villasante AC, Mauro LM, Perez CI, Schachner LA, Jimenez JJ. Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model. Cell Stress Chaperones. 2012;17(2):267–74.
Anbalangan K, Sadique J. Influence of an Indian medicine (Ashwagandha) on acute-phase reactants in inflammation. Indian J Exp Biol. 1981;19:245–9.
Bone K. Clinical applications of Ayurvedic and Chinese herbs. Warwick: Phytotherapy Press; 1996. p. 137–41.
Towatari K, Yoshida K, Mori N, Shimizu K, Kondo R, Sakai K. Polyphenols from the heartwood of Cercidiphyllum japonicum and their effects on proliferation of mouse hair epithelial cells. Planta Med. 2002;68(11):995–8.
Kamimura A, Takahashi T. Procyanidin B-2, extracted from apples, promotes hair growth: a laboratory study. Br J Dermatol. 2002;146(1):41–51.
Kamimura A, Takahashi T, Watanabe Y. Investigation of topical application of procyanidin B-2 from apple to identify its potential use as a hair growing agent. Phytomedicine. 2000;7(6):529–36.
Takahashi T, Kamimura A, Yokoo Y, Honda S, Watanabe Y. The first clinical trial of topical application of procyanidin B-2 to investigate its potential as a hair growing agent. Phytother Res. 2001;15(4):331–6.
Tenore GC, Caruso D, Buonomo G, D’Avino M, Santamaria R, Irace C, et al. Annurca apple nutraceutical formulation enhances keratin expression in a human model of skin and promotes hair growth and tropism in a randomized clinical trial. J Med Food. 2018;21(1):90–103.
Shin HS, Lee JM, Park SY, Yang JE, Kim JH, Yi TH. Hair growth activity of Crataegus pinnatifida on C57BL/6 mouse model. Phytother Res. 2013;27(9):1352–7.
Shao LX. [Effects of the extract from bergamot and boxthorn on the delay of skin aging and hair growth in mice]. Zhongguo Zhong Yao Za Zhi. 2003;28(8):766–9.
Dhanotia R, Chauhan NS, Saraf DK, Dixit VK. Effect of Citrullus colocynthis Schrad fruits on testosterone-induced alopecia. Nat Prod Res. 2011;25(15):1432–43.
Roy RK, Thakur M, Dixit VK. Development and evaluation of polyherbal formulation for hair growth-promoting activity. J Cosmet Dermatol. 2007;6(2):108–12.
Patel S, Sharma V, Chauhan NS, Dixit VK. An updated review on the parasitic herb of Cuscuta reflexa Roxb. Zhong Xi Yi Jie He Xue Bao. 2012;10(3):249–55.
Hornfeldt CS. Growing evidence of the beneficial effects of a marine protein-based dietary supplement for treating hair loss. J Cosmet Dermatol. 2018;17(2):209–13.
Hornfeldt CS, Holland M, Bucay VW, Roberts WE, Waldorf HA, Dayan SH. The safety and efficacy of a sustainable marine extract for the treatment of thinning hair: a summary of new clinical research and results from a panel discussion on the problem of thinning hair and current treatments. J Drugs Dermatol. 2015;14(9):s15–22.
Colombo VE, Gerber F, Bronhofer M, Floersheim GL. Treatment of brittle fingernails and onychoschizia with biotin: scanning electron microscopy. J Am Acad Dermatol. 1990;23(6 Pt 1):1127–32.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Almohanna, H.M., Ahmed, A.A., Tosti, A. (2020). Role of Oral Supplements: When and How to Choose. In: Tosti, A., Asz-Sigall, D., Pirmez, R. (eds) Hair and Scalp Treatments. Springer, Cham. https://doi.org/10.1007/978-3-030-21555-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-21555-2_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21554-5
Online ISBN: 978-3-030-21555-2
eBook Packages: MedicineMedicine (R0)